Creation of a lipoprotein(a) model to forecast progression-free survival and severe adverse events in metastatic lung adenocarcinoma patients lacking driver genes and with PD-L1 TPS under 50% - Quiz - MDSpire

Creation of a lipoprotein(a) model to forecast progression-free survival and severe adverse events in metastatic lung adenocarcinoma patients lacking driver genes and with PD-L1 TPS under 50%

  • By

  • Sicong Li

  • Yiyuan Cui

  • Yijing Yan

  • Hao Li

  • Yue Jin

  • Yufan Chen

  • Jingjie Yu

  • Li Feng

  • April 24, 2026

  • 0 min

Share

Original Source(s)

Creation of a lipoprotein(a) model to forecast progression-free survival and severe adverse events in metastatic lung adenocarcinoma patients lacking driver genes and with PD-L1 TPS under 50%

  • by Sicong Li, Yiyuan Cui, Yijing Yan, Hao Li, Yue Jin, Yufan Chen, Jingjie Yu, Li Feng

  • April 24, 2026

Related Content

Medical Oddities: Chew on This Cancer Prevention Idea

From gum to gut to memory—medicine gets weirdly clever fast 

The Frequency and Contributing Factors of Pulmonary Infections in Lung Cancer Patients Undergoing Treatment with Immune Checkpoint Inhibitors

Case Report: Nasal swelling and ulceration as a unique immune-related cutaneous adverse event of atezolizumab in small cell lung cancer